4091.T
Nippon Sanso Holdings Corporation

Basic Materials · Chemicals · valued as of 2026-11-03 · statements 2026-03-31

Average Intrinsic Value

10.44B USD

Market Cap

14.77B USD

Margin of Safety

-41.5%

Intrinsic / Market Ratio

0.71×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

9.78B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

11.70B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

9.84B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

10.44B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

10.44B USD

from the sum above

Market Cap

14.77B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.71×

the ratio the screener ranks by; Margin of Safety -41.5% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 9.78B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)13.00B USD
−②Net Debt Today4.32B USD
+③Growth Value1.10B USD
=Value9.78B USD

EPV of the Operations (NOPAT over WACC)

13.00B USD

Net debt today

-4.32B USD

Growth Value

+1.10B USD

Value

9.78B USD

①EPV (earnings power value)

13.00B USD

②Net Debt Today

4.32B USD

③Growth Value

1.10B USD

Market value

Market Cap14.77B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-51.1%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 11.70B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE5.48B USD
+②Equity at Year 15, Today6.22B USD
=Value11.70B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

5.48B USD

②Equity at Year 15, Today

6.22B USD

Market value

Market Cap14.77B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-26.3%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 9.84B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF7.23B USD
+②Invested Capital at Year 15, Today6.93B USD
−③Net Debt Today4.32B USD
=Value9.84B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

7.23B USD

②Invested Capital at Year 15, Today

6.93B USD

③Net Debt Today

4.32B USD

Market value

Market Cap14.77B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-50.1%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 5.64%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.42×Market Risk Premium 6.00%= 7.02%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 306.26M USDPretax Income 1.11B USD= 27.66%

The tax the interest saves.

Interest Expense =EBIT 1,256.87M USD−Pretax Income 1,107.12M USD= 149.75M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 149.75M USDTotal Debt 5.52B USD×(1 − Tax Rate for WACC 27.66%)= 1.96%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 5.52B USDMarket Cap + Total Debt 14.77B USD + 5.52B USD= 27.21%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 72.79%×Cost of Equity 7.02%+Debt Weight 27.21%×Cost of Debt 1.96%= 5.64%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 17.33B USD − Total Liabilities 9.44B USD = Book Value Today 7.89B USD

Total Debt 5.52B USD − Cash and Short-Term Investments 1.20B USD = Net Debt Today 4.32B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.0%at most 5%passes432,853,497 / 432,857,823
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.4%at least -10.0%passes(1.71B USD − 775.86M USD) ÷ 17.33B USD
Price to bookMarket Cap ÷ Book Value Today1.87×at most 3×passes14.77B USD ÷ 7.89B USD
Operating marginOperating Income ÷ Revenue14.2%above 10.0%passes1.21B USD ÷ 8.51B USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-2.7%above 10.0%does not pass8.51B USD / 8.75B USD
Net cash(Cash − Total Debt) ÷ Market Cap-30.4%above -30%does not pass(1.04B USD − 5.52B USD) ÷ 14.77B USD
Operating efficiencyOperating Income ÷ Gross Profit33.2%above 25.0%passes1.21B USD ÷ 3.65B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

5352.35 JPY

Enterprise value

3.06T JPY

the provider's own figure

EV / EBITDA

9.14×

Price / book

1.83×

the provider's book

Price / earnings

18.67×

Return on equity

12.1%

the provider's figure, not this page's

Profit margin

9.9%

Revenue growth

14.9%

Analyst target, mean

6218.71 JPY

Analysts

8

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

8.92B8.30B8.75B8.51B

Gross profit

3.30B3.38B3.65B3.65B

Operating income

871.52M1.11B1.08B1.21B

EBITDA

operating income before depreciation and amortisation

1.71B1.91B1.91B2.05B

Pretax income

792.85M996.24M971.93M1.11B

Net income

549.19M699.99M660.87M775.86M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

549.19M699.99M660.87M775.86M

R&D

————
Balance sheet, year end

Total assets

16.22B15.92B16.18B17.33B

Total liabilities

10.53B9.67B9.35B9.44B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

5.44B6.04B6.56B7.62B

Total debt

6.76B5.88B5.69B5.52B

Cash and equivalents

993.61M833.51M966.95M1.04B

Net PP&E

fixed assets after depreciation

5.83B5.80B6.02B6.52B

Working capital

current assets less current liabilities

765.90M463.89M1.14B749.73M
Cash flow

Operating cash flow

1.41B1.43B1.57B1.71B

Capital expenditure

paid out, so below zero

-690.06M-782.25M-982.32M-683.57M

Depreciation and amortisation

794.56M743.21M777.40M794.73M

Free cash flow

operating cash flow plus capital expenditure

722.44M645.35M590.91M1.02B